Redwood Pharma AB reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported net loss was SEK 4.9 million compared to SEK 3.6 million a year ago. Basic loss per share from continuing operations was SEK 5 compared to SEK 17 a year ago.
For the full year, net loss was SEK 13.04 million compared to SEK 20.84 million a year ago. Basic loss per share from continuing operations was SEK 31 compared to SEK 71 a year ago.